Literature DB >> 12354034

A ligand-field analysis of the trensal (H(3)trensal = 2,2',2' '-tris(salicylideneimino)triethylamine) ligand. An application of the angular overlap model to lanthanides.

Bernadine M Flanagan1, Paul V Bernhardt, Elmars R Krausz, Stefan R Lüthi, Mark J Riley.   

Abstract

The spectral and geometric trends of Ln(trensal) complexes (H(3)trensal = 2,2',2' '-tris(salicylideneimino)triethylamine) along the lanthanide series are analyzed. Low-temperature polarized absorption and luminescence spectra are reported for nine of the complexes with transitions suitable for analysis. Both the angular and radial geometry variations as a function of the lanthanide ion are quantified. The structural parameters are related to the trend in the ligand field found from an analysis of the f-f transitions. The ligand-field analysis is fitted globally across the whole series accounting for the contraction of the f orbitals as a function of atomic number. This study establishes the utility of describing the ligand field of f electrons within the one-electron operator approach of the angular overlap model.

Entities:  

Year:  2002        PMID: 12354034     DOI: 10.1021/ic011276q

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Determination of the electronic structure of a dinuclear dysprosium single molecule magnet without symmetry idealization.

Authors:  Mauro Perfetti; Maren Gysler; Yvonne Rechkemmer-Patalen; Peng Zhang; Hatice Taştan; Florian Fischer; Julia Netz; Wolfgang Frey; Lucas W Zimmermann; Thomas Schleid; Michael Hakl; Milan Orlita; Liviu Ungur; Liviu Chibotaru; Theis Brock-Nannestad; Stergios Piligkos; Joris van Slageren
Journal:  Chem Sci       Date:  2018-12-12       Impact factor: 9.825

2.  Analysis of vibronic coupling in a 4f molecular magnet with FIRMS.

Authors:  Jon G C Kragskow; Jonathan Marbey; Christian D Buch; Joscha Nehrkorn; Mykhaylo Ozerov; Stergios Piligkos; Stephen Hill; Nicholas F Chilton
Journal:  Nat Commun       Date:  2022-02-11       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.